top of page
PHA Canada
More actions
Profile
Join date: Jun 6, 2024
Posts (68)
Jun 9, 2025 ∙ 1 min
IV selexipag can be used as a bridging therapy
Pulmonary arterial hypertension patients who take selexipag normally take it orally (as a pill). Sometimes, though, this is temporarily...
1
0
Jun 3, 2025 ∙ 1 min
Quick Facts: What is Yutrepia?
What it is Yutrepia is a new drug: an inhaled form of treprostinil, a prostacyclin analogue. It was just approved by the Food and Drug...
47
2
May 29, 2025 ∙ 2 min
From Diagnosis to Advocacy: Heather’s PAH Journey
I was diagnosed with pulmonary arterial hypertension (PAH) in June 2024. In hindsight, knowing the symptoms as I do now, I might have had...
316
0
bottom of page